Alerts will be sent to your verified email
Verify EmailHEMORGANIC
|
Hemo Organic
|
Hind Bio Sciences
|
Ganga Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
38.07 % | 3.66 % | 0.71 % |
|
5yr average Equity Multiplier
|
-1.56 | 3.76 | 1.37 |
|
5yr Average Asset Turnover Ratio
|
0.14 | 0.25 | 0.31 |
|
5yr Avg Net Profit Margin
|
-763.22 % | -39.56 % | 1.72 % |
|
Price to Book
|
53.03 | 8.47 | 0.0 |
|
P/E
|
0.0 | 0.0 | 89.76 |
|
5yr Avg Cash Conversion Cycle
|
100.48 Days | 197.57 Days | 237.0 Days |
|
Inventory Days
|
406.93 Days | 0.0 | 165.67 Days |
|
Days Receivable
|
196.55 Days | 198.39 Days | 126.89 Days |
|
Days Payable
|
2776.86 Days | 104.32 Days | 119.78 Days |
|
5yr Average Interest Coverage Ratio
|
-250.54 | -32.49 | 1.32 |
|
5yr Avg ROCE
|
37.52 % | -14.28 % | 3.77 % |
|
5yr Avg Operating Profit Margin
|
-745.72 % | -38.68 % | 0.19 % |
|
5 yr average Debt to Equity
|
-0.73 | 2.68 | 0.28 |
|
5yr CAGR Net Profit
|
n/a | n/a | 31.95 % |
|
5yr Average Return on Assets
|
-33.34 % | -8.2 % | 0.53 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
16.85 % | 12.19 % | 50.91 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -15.8 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Hemo Organic
|
Hind Bio Sciences
|
Ganga Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|